-
Signature
-
/s/ F. Mark Reuter as Attorney-in-Fact for James E. Galeese
-
Issuer symbol
-
LYTS
-
Transactions as of
-
30 Jun 2025
-
Net transactions value
-
+$102,971
-
Form type
-
5
-
Filing time
-
12 Aug 2025, 08:57:19 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Galeese James E |
Executive VP; CFO |
LSI INDUSTRIES INC., 10000 ALLIANCE RD, CINCINNATI |
/s/ F. Mark Reuter as Attorney-in-Fact for James E. Galeese |
12 Aug 2025 |
0001708704 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
LYTS |
Common Stock |
Award |
$3,851 |
+254 |
+0.37% |
$15.16 |
68,570 |
12 Jul 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,864 |
+240 |
+0.35% |
$16.10 |
68,811 |
26 Jul 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,854 |
+268 |
+0.39% |
$14.38 |
69,079 |
09 Aug 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,878 |
+252 |
+0.36% |
$15.39 |
69,331 |
23 Aug 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,863 |
+252 |
+0.36% |
$15.33 |
69,582 |
06 Sep 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,978 |
+248 |
+0.36% |
$16.04 |
69,830 |
20 Sep 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,969 |
+242 |
+0.35% |
$16.40 |
70,073 |
04 Oct 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,979 |
+238 |
+0.34% |
$16.72 |
70,310 |
18 Oct 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,974 |
+241 |
+0.34% |
$16.49 |
70,551 |
01 Nov 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,994 |
+199 |
+0.28% |
$20.07 |
70,750 |
15 Nov 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,986 |
+195 |
+0.28% |
$20.44 |
70,945 |
29 Nov 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,984 |
+198 |
+0.28% |
$20.12 |
71,143 |
13 Dec 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,983 |
+205 |
+0.29% |
$19.43 |
71,348 |
27 Dec 2024 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,981 |
+218 |
+0.31% |
$18.26 |
71,566 |
10 Jan 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,974 |
+180 |
+0.25% |
$22.08 |
71,747 |
24 Jan 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,975 |
+189 |
+0.26% |
$21.03 |
71,936 |
07 Feb 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,987 |
+207 |
+0.29% |
$19.26 |
72,143 |
21 Feb 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,997 |
+228 |
+0.32% |
$17.53 |
72,371 |
07 Mar 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,969 |
+229 |
+0.32% |
$17.33 |
72,600 |
21 Mar 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,986 |
+259 |
+0.36% |
$15.39 |
72,858 |
04 Apr 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,997 |
+253 |
+0.35% |
$15.80 |
73,111 |
18 Apr 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,988 |
+250 |
+0.34% |
$15.95 |
73,361 |
02 May 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$4,000 |
+246 |
+0.34% |
$16.26 |
73,607 |
16 May 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,970 |
+244 |
+0.33% |
$16.27 |
73,851 |
30 May 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,995 |
+248 |
+0.34% |
$16.11 |
74,099 |
13 Jun 2025 |
Direct |
F1 |
| transaction |
LYTS |
Common Stock |
Award |
$3,997 |
+234 |
+0.32% |
$17.08 |
74,333 |
27 Jun 2025 |
Direct |
F1 |
| holding |
LYTS |
Common Stock |
|
|
|
|
|
134,788 |
30 Jun 2025 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: